Alessandra Cereghetti

机构：University Hospital Zurich · ORCID：0000-0003-1310-5234

发表论文 12 篇 · 总被引 112 次 · h-index 3

代表论文

Amphiphilic nanoparticle delivery enhances the anticancer efficacy of a TLR7 ligand via local immune activation (2018 · Biomaterials · 被引 60)
Guadecitabine increases response to combined anti-CTLA-4 and anti-PD-1 treatment in mouse melanoma in vivo by controlling T-cells, myeloid derived suppressor and NK cells (2023 · Journal of Experimental & Clinical Cancer Research · 被引 31)
Combinatorial Treatment with PARP and MAPK Inhibitors Overcomes Phenotype Switch-Driven Drug Resistance in Advanced Melanoma (2023 · Cancer Research · 被引 20)
Guadecitabine increases response to combined anti-CTLA-4 and anti-PD-1 treatment in mouse melanoma in vivo by controlling the responses of T-cells, myeloid derived suppressor cells and NK cells (2023 · Research Square · 被引 1)
DNA Methyltransferase Inhibition Upregulates the Costimulatory Molecule ICAM-1 and the Immunogenic Phenotype of Melanoma Cells (2024 · JID Innovations)
Supplementary Data from Combinatorial Treatment with PARP and MAPK Inhibitors Overcomes Phenotype Switch-Driven Drug Resistance in Advanced Melanoma (2023)